KCT0000392已完成未知
Changes in overactive bladder symptoms after withdrawl of solifenacin following intitial 12-week combination therapy with tamsulosin: A multicenter prospective study in men with benign prostatic hyperplasia and coexisting overactive bladder
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 45(Year) 至 o Limit（—）
- 性别
- Male
入选标准
- •Elligible patients are men 45 years or older with a total International Prostate Symptom Score (IPSS) of 8 or higher, a total overactive bladder symptoms score (OABSS) of 3 or higher and a score of 3rd item (urgency) of the OABSS of at least 2, and findings suggestive of BPH on transrectal ultrasonography.
排除标准
- •Those with acute urinary tract infection, significant renal dysfunction, significant hepatic dysfunction, a history of stroke or Parkinsonism, or a history of prostate cancer or PSA of 10ng/ml or more will be excluded.
- •And those with postvoid residual urine (PVR) more than 100ml, or maximum flow rate less than 8ml/s will be excluded
研究者
相似试验
已完成
不适用
Overactive bladder symptoms in women with pelvic organ prolapse before and after surgeryCondition 1: Overactive bladder. Condition 2: Pelvic organ prolapse.Other specified disorders of bladderOther female genital prolapseIRCT2016020626387N1Vice Chancellor for research of Tehran University of Medical Sciences159
招募中
不适用
Examination of the effect of overactive bladder treatment on female sexual functiooveractive bladderJPRN-UMIN000043168Sapporo Medical University100
招募中
不适用
Bladder function in patients with overactive bladder after cystocele repairIRCT20201108049307N1Esfahan University of Medical Sciences50
Unknown
不适用
Study on Bladder and Sexual Function Change After Simple HysterectomyBenign Uterine DiseaseNCT01683890Asan Medical Center300
已完成
不适用
evels of urinary OAB biomarker and voiding symptom score in bladder cancer patients recieving intravesical BCG therapyoveractive bladderJPRN-UMIN000011569Keio University School of Medicine, Department of Urology40